Lung Cancer – Symptoms, Diagnosis, and Advanced Treatment Options in Malaysia

Lung cancer is one of the most common and deadliest cancers worldwide. In Malaysia, it ranks among the top five most diagnosed cancers in both men and women. Despite its severity, early detection and new treatment strategies — including cell-based immunotherapy — are offering patients renewed hope.

At RCERT (Regional Cell Research & Therapy Centre), we are committed to advancing lung cancer care through modern diagnostics and next-generation therapies like immunotherapy, cell therapy, and personalized medicine.

🧬 What Is Lung Cancer?

Lung cancer occurs when cells in the lungs grow uncontrollably and form a tumor. Over time, these abnormal cells can invade surrounding tissues and metastasize (spread) to other parts of the body.

There are two main types:

1. Non-Small Cell Lung Cancer (NSCLC)

This is the most common form (about 85% of cases) and includes subtypes such as:

• Adenocarcinoma

• Squamous cell carcinoma

• Large cell carcinoma

2. Small Cell Lung Cancer (SCLC)

Less common but more aggressive. Often related to smoking and typically spreads faster.

⚠️ Risk Factors

Several factors increase the risk of developing lung cancer:

• Smoking (cigarettes, cigars, or pipes)

• Second-hand smoke exposure

• Exposure to asbestos, radon, or other industrial chemicals

• Air pollution

• Family history of lung cancer

• Chronic lung diseases (e.g., COPD, tuberculosis)

🩺 Symptoms of Lung Cancer

Many early-stage lung cancers are asymptomatic. When symptoms do appear, they may include:

• Persistent cough that doesn’t go away

• Coughing up blood (hemoptysis)

• Chest pain or discomfort

• Shortness of breath

• Hoarseness or wheezing

• Fatigue and unexplained weight loss

• Frequent respiratory infections (e.g., pneumonia)

If you or someone you know experiences these symptoms, early medical evaluation is crucial.

🧪 How Is Lung Cancer Diagnosed?

Diagnosis typically involves a combination of the following:

1. Medical History and Physical Exam

2. Chest X-ray or CT Scan

3. PET Scan (to check for metastasis)

4. Bronchoscopy or Needle Biopsy (to retrieve tumor tissue)

5. Molecular Testing to check for genetic mutations (EGFR, ALK, ROS1, etc.)

At RCERT, we also provide immune and genetic profiling to assess the suitability of patients for personalized treatments, including cell therapy.

🧬 Treatment Options for Lung Cancer

Treatment depends on the type, stage, and genetic profile of the cancer, as well as the patient’s overall health. Common treatments include:

1. Surgery

For early-stage lung cancer, removal of part or all of a lung may be recommended.

2. Radiation Therapy

Uses high-energy rays to kill or shrink tumors. Often combined with other treatments.

3. Chemotherapy

Traditional drug therapy used to kill rapidly growing cancer cells. Side effects can be significant.

4. Targeted Therapy

Drugs that specifically block cancer-causing genes like EGFR or ALK. Effective in patients with identifiable mutations.

5. Immunotherapy

Uses drugs like checkpoint inhibitors (e.g., PD-1/PD-L1 blockers) to reactivate the immune system to fight cancer.

6. Cell Therapy (RCERT Specialization)

Emerging cell-based treatments are offering personalized and less toxic alternatives. These include:

• DC-CIK Therapy: Combines dendritic cells and cytokine-induced killer cells to stimulate the immune system to destroy lung cancer cells.

• CAR-T Cell Therapy: For select advanced cases, reprogrammed T cells may be used to target tumor-specific antigens.

• Natural Killer (NK) Cells & TIL Cells: Offer non-MHC-restricted killing of cancer cells, especially in patients resistant to standard therapies.

• Exosome Therapy & MSC Supportive Care: May aid in tissue repair and immune balance during recovery.

🧪 Lung Cancer Research at RCERT

At RCERT, we are conducting advanced studies in:

• Immune cell profiling for lung cancer patients

• Personalized cell therapy protocols based on tumor type

• Collaboration with UNIMAS and Zhongrong Cell Technology, China

• DNA methylation tests for early detection and aging-related risks

Our Cell Processing Laboratory (cGMP-certified) and Clinical Centre in Malaysia ensure patients receive internationally compliant care.

🌍 Lung Cancer in Southeast Asia – A Growing Challenge

In the Southeast Asian region, lung cancer rates are rising, particularly among non-smoking women and urban populations exposed to pollution. Malaysia is now facing a dual burden:

• An aging population more susceptible to cancer

• Increasing exposure to carcinogens from the environment and lifestyle

RCERT is actively working with healthcare partners to develop affordable, scalable, and minimally invasive treatment pathways, including cell therapy for lung cancer patients.

🩺 Who Should Consider Cell Therapy?

Patients who may benefit from RCERT’s cell-based treatments include:

• Advanced-stage lung cancer patients not responding to chemotherapy

• Patients with poor tolerance to conventional treatments

• Individuals with recurring or metastatic cancer

• Patients interested in integrative cancer care and immunotherapy

• Candidates seeking personalized, immune-enhancing approaches

Every patient at RCERT undergoes a comprehensive evaluation, including imaging, tumor markers, and immune profiling, before any therapy is recommended.

⚖️ Safety and Side Effects of Cell Therapy

Cell-based therapies at RCERT are generally:

• Autologous (using patient’s own cells)

• Well-tolerated

• Non-toxic to healthy tissues

• Administered under close medical supervision

Compared to chemotherapy and radiation, patients experience fewer side effects, such as fatigue, nausea, or organ damage. Our therapies aim to enhance the immune response, not suppress it.

📈 Outlook & Survival

Lung cancer survival rates are improving thanks to early detection and newer treatments. When detected at an early stage, 5-year survival can exceed 60%. Unfortunately, most cases are detected late, where survival rates fall below 20%.

RCERT aims to change this reality by offering:

• Earlier detection through DNA methylation and imaging

• Safer, smarter therapies using the body’s own immune system

• Ongoing follow-up to monitor for recurrence or progression

📝 Conclusion

Lung cancer remains a serious health challenge, but with emerging therapies like DC-CIK, CAR-T, NK cells, and TIL cell therapy, there is new hope for patients — especially those who cannot tolerate or respond to traditional treatment.

At RCERT, our mission is to deliver next-generation solutions in cancer care using the latest breakthroughs in cell therapy and regenerative medicine, all from our base in Malaysia.

📞 Interested in a consultation or second opinion?
Contact RCERT today to explore your treatment options.